DOCSLIB.ORG

Final Program the 2012 International Neuropsychological Society Mid-Year Meeting/11Th Nordic Meeting in Neuropsychology June 27-30, 2012 Oslo, Norway

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Final Program the 2012 International Neuropsychological Society Mid-Year Meeting/11Th Nordic Meeting in Neuropsychology June 27-30, 2012 Oslo, Norway Final Program The 2012 International Neuropsychological Society Mid-Year Meeting/11th Nordic Meeting in Neuropsychology June 27-30, 2012 Oslo, Norway WEDNESDAY, JUNE 27, 2012 8:30–10:00 AM Invited Symposium: Adult ADHD — a Multifaceted Approach to Assessment and Intervention Co-Chairs: Liisa Klenberg, Laura Hokkanen København 1. HOKKANEN, L Adult ADHD – a Multifaceted Approach to Assessment and Intervention 2. LAASONEN, M Adult Dyslexia and ADHD in Finland – Project DyAdd 3. HELENIUS, P Impaired Neural Activation of the Ventral Attentional Pathway in ADHD 4. WASSERSTEIN, J Diagnosis of ADHD in Adults: Appropriate Symptom Threshold and the Role of Executive Function Measurement 5. WASSERSTEIN, J Nonpharmacological Treatment of Executive Dysfunction in Adults with ADHD 8:30–10:00 AM Paper Session: Cognitive Intervention/Rehabilitation Telemark 1. COVRE, P Reduction of Retroactive Interference may Improve Delayed Recall in Patients with Amnesia 2. ADLAM, AR Neurocognitive Interventions For Executive Function In Children Who Have Survived A Brain Injury 3. STUBBERUD, J Goal Management Training of Executive Functions in Patients with Spina Bifida 4. HERMANSEN GRUNEWALDT, K Computerized Working Memory Training in Very Low Birth Weight Children at Preschool Age 5. HASLAM, C Errorless Learning Enhances Memory in Children with Acquired Brain Injury 8:30–11:00 AM CE Workshop 1: Analysis of the Single Case in Clinical Practice: Quantitative Methods without Tears Presenter: John Crawford Oslo 1. CRAWFORD, JR Analysis of the single case in clinical practice: Quantitative methods without tears 8:30–11:00 AM CE Workshop 2: Evidence-Based Neuropsychological Assessment Presenter: Grant Iverson Helsingfors 1. IVERSON, GL Evidence-Based Neuropsychological Assessment 10:30 AM–12:00 PM Invited Symposium: Neuropsychological Studies in Autism from Denmark and Norway. Understanding Emotion in Music and Language, Metamemory and Characteristics of Children with Early Symptoms. Chair: Lennart Pedersen København 1. PEDERSEN, L Neuropsychological Studies in Autism from Denmark and Norway. Understanding Emotion in Music and Language, Metamemory and Characteristics of Children with Early Symptoms 2. GEBAUER, L Understanding Emotions in Music and Language 3. STENBERG, N Symptoms at 18 months and Autism Spectrum Disorder. A population based longitudinal study 4. ELMOSE, M Being aware of own performance: Metamemory in autism spectrum disorder 10:30 AM–12:00 PM Paper Session: Aging Telemark 1. FOSTER, JK Role of the ε4 Polymorphism of the APOE Gene in Cognitive Aging: A Statistical Mediation Analysis 2. SPAAN, PE A Verbal Description Variant of the Boston Naming Test: Improved Detection of Word Finding Difficulties in Normal Aging 3. HOGSTROM, LJ Age-Related Changes in Cortical Surface Area and Gyrification across the Adult Life-Span 4. LITERAKOVA, E Clock Drawing Test as a Diagnostic Tool for Distinction between Patients with Alzheimer’s Disease, Amnestic Mild Cognitive Impairment and Healthy Elderly: A Comparison of Three Scoring Systems 5. BOMBIN, I Compensation and Substitution are more Effective than Restitution in Improving Functional Independence and Memory in Amnestic MCI elderly subjects Downloaded from https://www.cambridge.org/core. IP address: 170.106.35.93, on 26 Sep 2021 at 06:47:11, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1355617712001063 ii Thursday, June 28, 2012 11:30 AM–2:00 PM CE Workshop 3: Unawareness of Deficit Following Various Brain Disorders: Implications for Assessment and Rehabilitation Presenter: George Prigatano Oslo 1. PRIGATANO, G Unawareness of Deficit Following Various Brain Disorders: Implications for Assessment and Rehabilitation 11:30 AM–2:00 PM CE Workshop 4: BRIEF as a Diagnostic and Intervention Instrument in Clinical Neuropsychology Presenter: Gerard Gioia Helsingfors 1. GIOIA, G BRIEF as a Diagnostic and Intervention Instrument in Clinical Neuropsychology 12:30–2:00 PM Paper Session: Psychopathology/Neuropsychiatry København 1. REINVALL, O Psychiatric Symptoms in Children and Adolescents with Autism Spectrum Disorders (ASD) 2. BARDER, HE Neurocognitive Development In First Episode Psychosis 5 year Follow-Up; How Do Relapses Affect The Course? 3. WOOD, SJ Neurocognitive Markers of Psychosis Onset and Functional Outcome 2 to 14 years After Identification as Ultra-high Risk for Psychosis 4. LEGRIS, JM Executive Function, Iowa Gambling Task Performance and Suicide Risk in Women with Borderline Personality Disorder 5. WHITTON, AE Pathological Disgust and the Basal Ganglia: An Examination of Disgust Responding in Obsessive-Compulsive Disorder 12:30–2:00 PM Paper Session: Assessment/Psychometrics/Methods Telemark 1. EGLE, J Psychometric properties of a computerized version of the Tower of London: Using item response theory to evaluate its dimensionality and construct validity 2. BOSNES, O Are US Norms with the WMS-III and WAIS-III Feasible in Norway? 3. SATCHI, N The Clinical Utility of The Behavior Rating Inventory of Executive Function- Adult Version (BRIEF-A) in patients with psychological disorders 4. SCHNABEL, R Neuropsychological Assessment of Distractibility in Mild Traumatic Brain Injury and Depression 5. HIETANEN, M Cognitive Impairment is Highly Common after Stroke Despite “Good” Clinical Recovery 2:45–3:00 PM Welcome Address Principal of the University of Oslo: Ole Petter Ottersen President of The Norwegian Neuropsychological Society: Erik Hessen University of Oslo Aula 3:00–3:45 PM Invited Address: Brain Maps For Space Speaker: Edvard Moser University of Oslo Aula 1. MOSER, E Brain Maps For Space 4:00–5:00 PM INS Presidential Address: Profiles Of Dementia: Neuropsychological, Neuroanatomical and Neuropathologic Phenotypes President of The International Neuropsychological Society: Sandra Weintraub University of Oslo Aula 1. WEINTRAUB, S Profiles Of Dementia: Neuropsychological, Neuroanatomical and Neuropathologic Phenotypes 6:00–6:45 PM Reception Oslo City Hall THURSDAY, JUNE 28, 2012 8:00–9:30 AM Invited Symposium: Disorders of Consciousness - Ethical Issues, Diagnostic and Prognostic Considerations and Treatment Options Chair: Marianne Løvstad Telemark 1. LØVSTAD, M Disorders of Consciousness - Ethical Issues, Diagnostic and Prognostic Considerations and Treatment Options 2. SCHNAKERS, C Pain Assessment and Pain Management in DOC Patients 3. FINS, JJ Ethical Decision-Making on Behalf of Patients with Disorders of Consciousness 4. GIACINO, JT A Systematic, Evidence-Based Approach to Diagnostic Assessment, Outcome Prediction and Rehabilitation in Patients with Disorders of Consciousness Downloaded from https://www.cambridge.org/core. IP address: 170.106.35.93, on 26 Sep 2021 at 06:47:11, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1355617712001063 Thursday, June 28, 2012 iii 8:00–9:30 AM Invited Symposium: Neurocognition in Psychotic Disorders: Change or Stability Co-Chairs: Merete G. Øie, Kjetil Sundet Helsingfors 1. ØIE, MG Neurocognition in Psychotic Disorders: Change or Stability 2. WOOD, SJ Change Over Time in Neurocognitive Performance in a Sample at Ultra-high Risk for Psychosis 3. REICHENBERG, A The First 10 Years: The Course of Neuropsychological Functioning in an Epidemiological Sample of First Episode Psychosis 4. HARVEY, PD Course of Everyday Functioning in Older Community Dwelling People with Schizophrenia: The influence of Cognition, Functional Capacity, and Illness History 8:00–9:30 AM Invited Symposium: Aging and Mild Cognitive Impairment Chair: Ivar Reinvang Oslo 1. REINVANG, I Aging and Mild Cognitive Impairment 2. FJELL, AM Structural Brain Changes in Aging 3. ZIEGLER, D Cognitive Control Networks in the Aging Brain 4. FALKENSTEIN, M The Influence of Different Training Regimes on Executive Functions and Brain Activity in Healthy Old Adults 5. NYBERG, L Association of MCI in Parkinson’s Disease to Altered Fronto-striatal Functional Brain Activity 9:45–11:15 AM Symposium: Neuropsychological Functioning and Pharmacological Treatment of College Students with ADHD Chair: Lisa Weyandt Telemark 1. WEYANDT, L Neuropsychological Functioning and Pharmacological Treatment of College Students with ADHD 2. WEYANDT, L Executive Functions (EF) and Attention Deficit Hyperactivity Disorder (ADHD) 3. DUPAUL, GJ Effects of Lisdexamfetamine Dimesylate (LDX) on the Psychological and Academic Functioning of College Students with Attention-Deficit/Hyperactivity Disorder (ADHD) 4. SWETOSKY, A Executive Functioning in College Students with ADHD Symptomology 5. VERDI, GR Effects of Lisdexamfetamine Dimesylate (LDX) on the Executive Functioning of College Students with Attention- Deficit/Hyperactivity Disorder (ADHD) 9:45–11:15 AM Invited Symposium: Psychiatric Disorders following Traumatic Brain Injury Chair: Jennie Ponsford Discussant: Teresa Ashman Helsingfors 1. PONSFORD, J Psychiatric Disorders following Traumatic Brain Injury 2. DIKMEN, S The Natural History and Predictors of Depression following Civilian Traumatic Brain Injury 3. PONSFORD, J Psychopathology in the First Three Years After Traumatic Brain Injury 4. SCHÖNBERGER, M The Temporal Relationship Between Depression, Anxiety, and Functional Status after Traumatic Brain Injury: A Cross- lagged Analysis 5. MALEC, J Building a Preliminary Model for Post-TBI Depression 9:45–11:15 AM Invited Symposium: Risk Reduction Factors for Cognitive Decline in Older Adults Chair: Jennifer Manly Oslo 1. MANLY, J Risk
Load more

Recommended publications
  • Teleneuropsychology (Telenp) in Response to COVID-19: Practical Guidelines to Balancing Validity Concerns with Clinical Need
    Teleneuropsychology (TeleNP) in Response to COVID-19: Practical Guidelines to Balancing Validity Concerns with Clinical Need Rene Stolwyk, DPsych(Clin.Neuro), PsyBA Dustin B. Hammers, Ph.D., ABPP(CN) Senior Lecturer and Clinical Neuropsychologist Board Certified in Clinical Neuropsychology Turner Institute for Brain and Mental Health Associate Professor, Department of Neurology Monash University, Melbourne, Australia University of Utah, Salt Lake City, Utah Email: [email protected] Email: [email protected] Twitter: @rene_stolwyk Lana Harder, PhD, ABPP C. Munro Cullum, Ph.D., ABPP-CN Board Certified in Clinical Neuropsychology Professor of Psychiatry, Neurology, and Neurosurgery Board Certified Subspecialist in Pediatric Neuropsychology Pam Blumenthal Distinguished Professor of Clinical Psychology Children’s Medical Center Dallas Senior Neuropsychologist, O’Donnell Brain Institute Associate Professor of Psychiatry and Neurology University of Texas Southwestern Medical Center University of Texas Southwestern Medical Center Email: [email protected] Email: [email protected] INS Webinar Presented on 4/2/2020 Objectives Following this webinar, attendees will be able to: • Understand the evidence base supporting TeleNP procedures as well as the strengths and limitations of different models • Apply knowledge of models of TeleNP and evaluate potential feasibility within your own clinical settings • Understand key legal and ethical considerations when providing TeleNP services Outline • Ethical and Legal Challenges • Logistical and Practical Considerations • Models of TeleNP • Evidence for use of Specific Measures over TeleNP and Patient Satisfaction • Practical Considerations for Home-Based TeleNP Our Experience with TeleNP • Dr. Hammers leads the University of Utah TeleNP Program • Joint relationship between University of Utah Cognitive Disorders Clinic and St.
    [Show full text]
  • Submission for MD
    Submission for MD University of Limerick, Graduate Entry Medical School Student name: Henry O’Connell ID number: 12110213 Title: Detection and diagnosis of delirium: a study of the application of computer - assisted technologies. 1 | P a g e Table of Contents List of tables ............................................................................................................................................ 4 List of figures ........................................................................................................................................... 5 Abbreviations .......................................................................................................................................... 6 Acknowledgements ................................................................................................................................. 7 Assessments and scales used .................................................................................................................. 8 Rater A assessments ........................................................................................................................... 8 Rater B assessments ........................................................................................................................... 8 Abstract ................................................................................................................................................... 9 Background ....................................................................................................................................
    [Show full text]
  • Abstracts Presented at the Thirtieth Annual International Neuropsychological Society Conference
    VU Research Portal The impact of the early frontal lobe damage on the development of executive functions Smidts, D.P.; Anderson, V. published in Journal of the International Neuropsychological Society 2003 document version Publisher's PDF, also known as Version of record Link to publication in VU Research Portal citation for published version (APA) Smidts, D. P., & Anderson, V. (2003). The impact of the early frontal lobe damage on the development of executive functions. Journal of the International Neuropsychological Society, 8 (2). General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. E-mail address: [email protected] Download date: 03. Oct. 2021 Journal of the International Neuropsychological Society (2002), 8, 143–321. Copyright © 2002 INS. Published by Cambridge University Press. Printed in the USA. DOI: Abstracts Presented at the Thirtieth Annual International Neuropsychological Society Conference February 13–16, 2002 Toronto, Canada Wednesday Afternoon, February 13, 2002 Poster Session 1/4:00–7:00 p.m.
    [Show full text]
  • Abstract Book
    Plenary Abstracts PL01 Date: Friday 22 April 2016 Session: Advances Towards Prevention, Treatment and Cure LATEST DIAGNOSIS AND TREATMENT 2016 Serge Gauthier1 1McGill Center for Studies in Aging, AD Research Unit, H4H 1R3, Montreal, 6825 LaSalle Boulevard, CANADA Abstract: There are ongoing efforts at harmonizing research diagnostic criteria for Alzheimer’s disease (AD) throughout its stages (asymptomatic at risk, MCI, dementia). This will facilitate research on prevention using non-pharmacologic and pharmacologic strategies. There is a concerted effort from governments, regulators, the pharmaceutical industry and investigators to accelerate the pace of therapeutic research through all these stages of AD. Recruiting for therapeutic research will be facilitated by the involvement of persons at risk and patients through “trial ready cohorts”. The increasing use of biomarkers measuring the amount of amyloid and tau pathology in the brain may help to choose the right treatment for the right person at the right stage of disease. In the near future combinations of treatments will be tried, and we need to learn from the fields of infectious disease and cancer about trial design, practice guidelines and costs sharing. National plans will help implement current and future diagnostic and treatment strategies world-wide. Keywords: research 2 | www.adi2016.org @ADIConferenve / ADI2016 Plenary Abstracts PL02 Date: Friday 22 April 2016 Session: Advances Towards Prevention, Treatment and Cure THE WELL-EDUCATED LAB RAT: A VIEW OF CLINICAL RESEARCH FROM
    [Show full text]
  • Rehabilitation Information Pack a Range of Products from Pearson Assessment for Professionals Working in the Area of Rehabilitation
    Rehabilitation Information Pack A range of products from Pearson Assessment for professionals working in the area of rehabilitation The Functional UK Administration and Scoring Manual TFL S Living Scale UK Edition Examiner’s Manual C. Munro Cullum Myron F. Weiner Kathleen C. Saine www.pearsonclinical.co.uk Welcome... Introducing our 2013 Rehabilitation Information Pack Dear Colleague, Pearson (Assessment) is one of the UK’s leading publishers of standardised assessments. Our tests are used by a number of professionals in both health and education settings and we strive to develop and distribute tools that are timely and in line with good practice guidelines. For example, we are mindful of targets set by the Department of Health, for the early recognition of debilitating neurological and cognitive disorders including dementia and the aim for ‘two-thirds of people with dementia [to be] identified and given appropriate support by 2015’. In this pack you will find a range of products that can aid you inidentifying cognitive impairments and assist you in the evaluation of your clients; helping you to plan intervention strategies and enhance your evidence- based practice. Among these assessments is the new Brief Cognitive Status Exam (BCSE) which is designed to assess a client’s cognitive ability quickly and reliably, and the RBANS™ - Update which can be used as a stand-alone “core” battery for the detection and characterization of dementia in the elderly. Together with early diagnosis, assessment of activities of daily living can be vital in assisting service users maintain independence or return to everyday life. The UK-normed Rivermead Behavioural Memory Test- Third Edition, Rookwood Driving Battery and The Functional Living Scales – UK Version all have excellent ecological validity which places assessment in real life context; making the results more meaningful to you as a professional, and your clients.
    [Show full text]
  • Final Program, the International Neuropsychological Society
    Journal of the International Neuropsychological Society (2009 ), 1 5, Su ppl. 2. C opy right © INS. Published by Cambridge University Press, 2009. doi: 10.1017/S135561770 9 9 9 1044 Final Program The International Neuropsychological Society, Finnish Neuropsychological Society, Joint Mid-Year Meeting July 29-August 1, 2009 Helsinki, Finland & Tallinn, Estonia WEDNESDAY, JULY 29, 2009 9:00 AM–12:00 PM Continuing Education Course 1: Cerebral Palsy And Traumatic Brain Injury: A Family-Based Approach To The Rehabilitation Of The Child Presenter: Lucia Braga Press Room 9:00 AM–12:00 PM Continuing Education Course 2: Clinical & Psychometric Strategies For Improving Accuracy For Identifying Cognitive Impairment Presenter: Grant Iverson Fennia II 1:00–4:00 PM Continuing Education Course 3: Neuropsychotherapy: Guidelines For A New Integrated Field Of Neuropsychological Treatment Presenter: Ritva Laaksonen Fennia I 1:00–4:00 PM Continuing Education Course 4: The Functional Neuroanatomy Of Semantic Memory Presenter: Alex Martin Fennia II 1:00–4:00 PM Continuing Education Course 5: Neurodevelopmental Consequences Of Very Low Birth Weight: Current Knowledge And Implications Presenter: H. Gerry Taylor Press Room 4:15–4:45 PM Opening Ceremony Europaea 4:45–5:30 PM Presidential Address: Time, Language, and the Human Brain INS President: Michael Corballis Europaea 1. CORBALLIS, M Time, Language, and the Human Brain. 6:00–7:30 PM Helsinki City Reception Helsinki City Hall Downloaded from https://www.cambridge.org/core. IP address: 170.106.35.93, on 26 Sep 2021 at 02:03:36, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
    [Show full text]
  • ANNEXES COMPLEMENTAIRES Repérage Et Processus Menant Au
    ANNEXES COMPLEMENTAIRES Repérage et processus menant au diagnostic de la maladie d’Alzheimer et d’autres troubles neurocognitifs Octobre 2015 Une production de l’Institut national d’excellence en santé et en services sociaux Le présent document contient les annexes complémentaires au rapport « Repérage et processus menant au diagnostic de la maladie d'Alzheimer et d'autres troubles neurocognitifs ». Ces annexes et le rapport final sont accessibles en ligne dans la section Publications de notre site Web. Le contenu de cette publication a été rédigé et édité par l’INESSS. Renseignements Institut national d’excellence en santé et en services sociaux (INESSS) 2535, boulevard Laurier, 5e étage 2021, avenue Union, bureau 10.083 Québec (Québec) G1V 4M3 Montréal (Québec) H3A 2S9 Téléphone : 418 643-1339 Téléphone : 514 873-2563 Télécopieur : 418 646-8349 Télécopieur : 514 873-1369 [email protected] www.inesss.qc.ca Responsabilité L’Institut rend accessibles les principales informations qui ont servi à la préparation du rapport « Repérage et processus menant au diagnostic de la maladie d'Alzheimer et d'autres troubles neurocognitifs » aux lecteurs qui désirent plus de détails sur sa démarche scientifique. Ce document n’a pas fait l’objet d’une révision linguistique. Il ne reflète pas forcément les opinions des autres personnes consultées aux fins du présent dossier. TABLE DES MATIÈRES SIGLES ET ACRONYMES ................................................................................................................................ i ANNEXE A
    [Show full text]
  • Test Selection Process of a Neuropsychological Assessment
    Test selection Process of a neuropsychological assessment • Review of information provided by referrer and if possible review of medical records Gather • Interview with client and his/her relative or carer information • Purpose of assessment? • Screening test? • Which measure is appropriate for my client? Test selection • Fixed vs flexible battery • Awareness of standardisation procedures Test • Awareness of scoring principles administration and scoring What do you need to consider when selecting a test? ´ Practical considerations ´ How long will it take to administer? ´ What is the time available to assess? What is the patient’s tolerance for testing? ´ Do I have access to the test I want to use? ´ Is it sensitive enough to detect my client’s problems ´ Are there problems which make it practically difficult to administer the test? (e.g., sensory and motor problems) ´ Has testing been completed previously? ´ Are parallel forms available to allow comparison of performance over time? ´ Am I qualified to use the test? Balance between undertaking an adequate assessment and over assessing. Comprehensive Neuropsychological Cognitive Screening Tests Batteries • Potential uses • Potential uses • Early identification of individuals at • Determination of presence and magnitude potential risk for condition or disorder of impairment • May indicate need for further evaluation or • Determination of diagnoses intervention • Determination of functional status, abilities, • May be used to monitor progression of and capacities symptoms or response to intervention
    [Show full text]
  • On-Line Appendix References
    ON-LINE APPENDIX with the Clinical Dementia Rating scale.15 In agreement with the Neuropsychological Assessment Petersen criteria,16 participants having a CDR score of 0.5 but no At baseline, all individuals underwent a detailed neuropsycholog- dementia and a score exceeding 1.5 SDs below the age-appropri- ical assessment. The control participants were evaluated with an ate mean in any of the above tests were confirmed as to their MCI extensive neuropsychological battery, including the MMSE,1 the status. Hospital Anxiety and Depression Scale,2 and the Lawton Instru- 3 mental Activities of Daily Living. Their cognitive assessment in- REFERENCES 4 cluded the following: 1) attention (Digit Symbol Code, Trail- 1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a prac- Making Test A5); 2) working memory (verbal: Digit Span tical method for grading the cognitive state of patients for the clini- Forward4; visuospatial: Visual Memory Span Forward4); 3) epi- cian. J Psychiatr Res 1975;12:189–98 CrossRef Medline sodic memory (verbal: RI-48 Cued Recall Test6; visual: Shapes 2. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. 7 5 Acta Psychiatr Scand 1983;67:361–70 CrossRef Medline Test ); 4) executive functions: (Trail-Making Test B, Wisconsin 3. Barberger-Gateau P, Commenges D, Gagnon M, et al. Instrumental 8 9 Card Sorting Test, Phonemic Verbal Fluency Test ); 5) language activities of daily living as a screening tool for cognitive impairment (Boston Naming Test10); 6) visual gnosis (Ghent Overlapping and dementia in elderly community dwellers. J Am Geriatr Soc 1992; Figures11); 7) praxis: ideomotor,12 reflexive,13 and constructional 40:1129–34 CrossRef Medline (Consortium to Establish a Registry for Alzheimer Disease, figure 4.
    [Show full text]
  • 7.07 Neuropsychological Assessment of the Elderly
    Copyright © 1998 Elsevier Science Ltd. All rights reserved. 7.07 Neuropsychological Assessment of the Elderly JOHN R. CRAWFORD and ANNALENA VENNERI University of Aberdeen, UK and RONAN E. O'CARROLL University of Stirling, UK 7.07.1 THE AIMS OF NEUROPSYCHOLOGICAL ASSESSMENT 134 7.07.2 SOME SPECIFIC CONSIDERATIONS IN NEUROPSYCHOLOGICAL ASSESSMENT OF THE ELDERLY 135 7.07.3 THE NEUROPSYCHOLOGICAL INTERVIEW 136 7.07.4 BASIC PSYCHOMETRIC ISSUES 137 7.07.4.1 The Rationale of Deficit Measurement in Clinical Practice 137 7.07.4.2 Converting Scores to a Common Measurement Scale 137 7.07.4.3 Reliability 138 7.07.4.4 Reliable vs. Abnormal Differences 138 7.07.4.5 Monitoring Change 139 7.07.5 APPROACHES TO ASSESSMENT IN CLINICAL NEUROPSYCHOLOGY 140 7.07.6 SCREENING TESTS FOR MENTAL STATUS 141 7.07.7 MEASURES OF CURRENT INTELLECTUAL ABILITY 141 7.07.7.1 Use of the WAIS-R with the Elderly 141 7.07.7.2 Analysis of Subtest Profiles 142 7.07.7.3 WAIS-R Factor Scores 144 7.07.8 SPECIFIC METHODS FOR THE ESTIMATION OF PREMORBID ABILITY 145 7.07.9 AGING AND MEMORY 146 7.07.9.1 Introduction to Aging and Memory 146 7.07.9.2 Age-associated Memory Impairment 147 7.07.9.3 Does Memory Functioning in Dementia Represent Accelerated Aging? 147 7.07.9.4 Commonly Used Memory Tests: Implications for use with Elderly Subjects 147 7.07.9.4.1 The Auditory Verbal Learning Test 147 7.07.9.4.2 The California Verbal Learning Test 148 7.07.9.4.3 The Wechsler Memory Scale-Revised 148 7.07.9.4.4 The Rivermead Behavioural Memory Test 149 7.07.9.4.5 The Rey Complex Figure Test 149
    [Show full text]
  • Aspects of the Neuropsychological Development and Assessment of New Zealand Children
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. Aspects of the Neuropsychological Development and Assessment of New Zealand Children A thesis presented in partial fulfilment of the requirements for the degree of Doctor of Clinical Psychology at Massey University, Wellington, New Zealand. Kate Sarah Ross-McAlpine 2018 Abstract Typical neuropsychological development in school age children is an under-researched area. There is insufficient research on age effects on performance, relationships between multiple cognitive abilities and between these abilities and academic achievement. In addition to this, there has been no research conducted on neuropsychological assessment practices with children in New Zealand (NZ). This thesis explored patterns of neuropsychological development in typically developing children and provides clarity on the current practices of psychologists conducting neuropsychological assessment with children in NZ. Study 1 explored the age effects on neuropsychological measures for typically developing children aged 6 to 11 years. Firstly, the scaled scores of NZ children were compared with overseas normative groups and found to be within ±0.4 of a standard deviation for all tests except for finger tapping and animal sorting (NEPSY-II). Secondly, age effects were found for all measures of cognitive abilities which is consistent with previous research. Post-hoc findings identified that the most significant improvement occurred between ages 6 and 9 years. The existence of differences between NZ and USA samples, specifically found for animal sorting and finger tapping (NEPSY-II), indicates that New Zealand normative data would be beneficial for some subtests used in neuropsychological assessments.
    [Show full text]
  • Abstracts Presented at the Thirtieth Annual International Neuropsychological Society Conference
    Journal of the International Neuropsychological Society (2002), 8, 143–321. Copyright © 2002 INS. Published by Cambridge University Press. Printed in the USA. DOI: Abstracts Presented at the Thirtieth Annual International Neuropsychological Society Conference February 13–16, 2002 Toronto, Canada Wednesday Afternoon, February 13, 2002 Poster Session 1/4:00–7:00 p.m. 3-stage odor discrimination test prior to participation. Multivariate analy- ses revealed a decline in recognition accuracy with age across all 3 do- mains, with less impairment in figural memory among individuals older AGING than 60. Moreover, age-related changes in odor memory were not related to changes in verbal or figural recognition. On the figural recognition task, T. KOGURE & T. HATTA. Temporal Memory Illusion of Social Events older individuals demonstrated more liberal response biases than did youn- in Older and Younger Adults. ger participants. Age-related differences in recognition discrimination and Even though people could remember precise contents of a social event response bias were not accounted for by global cognitive function, smok- (e.g., news event) that happened previously, the time of the event occur- ing history, sex, or ethnicity. These findings suggest that odor recognition rence could hardly be retrieved accurately. People sometimes estimate the declines with age, even among individuals with generally intact olfactory time of occurrence more recently than the actual time (telescoping bias), acuity. while they sometimes, in contrast, estimate the time of occurrence more Correspondence: Claire McGrath, Brain Behavior Laboratory, Neuropsy- remotely than the actual time (time expansion bias). The present study chiatry Section, University of Pennsylvania, Department of Psychiatry, examined aging effects of these temporal memory illusions.
    [Show full text]